This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
PSMA PET Imaging
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
Trials in Progress
Trials in Progress
ARAMON Trial
ARASEC Trial
ARASTEP Trial
ECLIPSE Trial
Oral EPI-7386
SPLASH Trial
Right Side
PCCTC
DORA
IRONMAN
PROMISE
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Kidney Cancer Today
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Suprapubic Catheter
Diane K. Newman, DNP FAAN BCB-PMD
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Education
Covid-19
The Prostate Cancer Foundation
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Pelvic Health & Reconstruction
Endourology
Testicular Cancer
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
AMA 2023
ASCO 2023
AUA 2023
ASCO GU 2023
All Conferences
View All
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Prostate Cancer
Recent Abstracts
mRNA expression signature of Gleason grade predicts lethal prostate cancer - Abstract
May 26, 2011
Webinar/CME: Advances in management of castrate-resistant prostate cancer
May 26, 2011
BJUI Mini Reviews - Effect of testosterone administration to men with prostate cancer is unpredictable: A word of caution and suggestions for a registry
May 26, 2011
AUA 2011 - Educational needs of urologists on bone health in prostate cancer - Poster
May 26, 2011
Brisk walking could improve prostate cancer outcomes
May 26, 2011
Preoperative insulin-like growth factor-binding protein-3 (IGFBP-3) blood level predicts Gleason sum upgrading - Abstract
May 25, 2011
Fracture risk in men with prostate cancer: A population-based study - Abstract
May 25, 2011
Broccoli-derived phytochemicals indole-3-carbinol and 3,3'-diindolylmethane exerts concentration-dependent pleiotropic effects on prostate cancer cells: Comparison with other cancer preventive phytochemicals - Abstract
May 25, 2011
Low-dose docetaxel in combination with dexamethasone for hormone-refractory prostate cancer - Abstract
May 25, 2011
Quantification of prostate deformation due to needle insertion during TRUS-guided biopsy: Comparison of hand-held and mechanically stabilized systems - Abstract
May 25, 2011
Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: Preliminary results - Abstract
May 25, 2011
Current clinical trials in castrate-resistant prostate cancer - Abstract
May 25, 2011
Prostate cancer radiotherapy in Austria : Overview on number of patients, intention to treat, and treatment techniques based on data from 2007 - Abstract
May 25, 2011
Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy - Abstract
May 25, 2011
BJUI Mini Reviews - Focal therapy in the management of localized prostate cancer
May 25, 2011
The Association between pre-operative PSA and prostate cancer-specific mortality in patients with long-term follow-up after radical prostatectomy - Abstract
May 24, 2011
Survival is associated with time to reach PSA nadir (DAN) and the ratio DAN/nadir value after androgen deprivation for prostate cancer - Abstract
May 24, 2011
Prostate cancer risk variants are not associated with disease progression - Abstract
May 24, 2011
Impact of diabetes mellitus on the detection of prostate cancer via contemporary multi (≥12)-core prostate biopsy - Abstract
May 24, 2011
Treatment decision-making for localized prostate cancer: What younger men choose and why - Abstract
May 24, 2011
Page 1266 of 1306
Start
Prev
1261
1262
1263
1264
1265
1266
1267
1268
1269
1270
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free
